SFN68 is a humanized IgG1 neutralizing monoclonal antibody targeting HGF. It significantly inhibits the interaction between HGF and c-Met, the activation of c-Met, and HGF-mediated cell scattering and proliferation. SFN68 is applicable for cancer research.
Target:
c-Met/HGFR
* VAT and and shipping costs not included. Errors and price changes excepted
